Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.52 -0.02 (-1.30%)
At close: Nov 11, 2026 · 4:00 PM EST

Zhengye Biotechnology Holding (ZYBT) Other Accumulated Expenses (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) posted Other Accumulated Expenses of $20,585 for the quarter ended Dec 31, 2025, up 1.3% from $20,325 a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Other Accumulated Expenses came in at -$146,000.

  • In prior years, Zhengye Biotechnology Holding's Other Accumulated Expenses was $20,000 in the year ended Dec 31, 2024, -$5.77 million in the year ended Dec 31, 2023 and -$5.15 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zhengye Biotechnology Holding 72.98 Mn 69.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 56,745.90
Jun 30, 2025 58,000.00
Dec 31, 2024 76,184.21
Dec 31, 2023 118,334.04
API Access

Zhengye Biotechnology Holding Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ZYBT&period=max&api_key=YOUR_API_KEY